As of 2025-07-09, the Relative Valuation of Royalty Pharma PLC (RPRX) is 35.60 USD. This relative valuation is based on P/E multiples. With the latest stock price at 35.51 USD, the upside of Royalty Pharma PLC based on Relative Valuation is 0.2%.
The range of the Relative Valuation is 34.54 - 36.75 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 18.7x | 18.4x |
| Forward P/E multiples | 20.0x - 21.3x | 20.5x |
| Fair Price | 34.54 - 36.75 | 35.60 |
| Upside | -2.7% - 3.5% | 0.2% |
| Date | P/E |
| 2025-07-08 | 18.27 |
| 2025-07-07 | 18.31 |
| 2025-07-03 | 18.72 |
| 2025-07-02 | 18.62 |
| 2025-07-01 | 18.46 |
| 2025-06-30 | 18.54 |
| 2025-06-27 | 18.46 |
| 2025-06-26 | 18.15 |
| 2025-06-25 | 18.48 |
| 2025-06-24 | 18.60 |
| 2025-06-23 | 18.22 |
| 2025-06-20 | 17.94 |
| 2025-06-18 | 17.97 |
| 2025-06-17 | 17.78 |
| 2025-06-16 | 18.06 |
| 2025-06-13 | 17.93 |
| 2025-06-12 | 18.15 |
| 2025-06-11 | 17.52 |
| 2025-06-10 | 17.28 |
| 2025-06-09 | 17.18 |
| 2025-06-06 | 17.38 |
| 2025-06-05 | 17.37 |
| 2025-06-04 | 17.21 |
| 2025-06-03 | 17.13 |
| 2025-06-02 | 17.12 |
| 2025-05-30 | 16.92 |
| 2025-05-29 | 16.80 |
| 2025-05-28 | 16.79 |
| 2025-05-27 | 16.82 |
| 2025-05-23 | 16.70 |
| 2025-05-22 | 16.63 |
| 2025-05-21 | 16.89 |
| 2025-05-20 | 17.03 |
| 2025-05-19 | 17.63 |
| 2025-05-16 | 17.51 |
| 2025-05-15 | 17.04 |
| 2025-05-14 | 16.62 |
| 2025-05-13 | 16.89 |
| 2025-05-12 | 17.16 |
| 2025-05-09 | 17.06 |
| 2025-05-08 | 17.03 |
| 2025-05-07 | 16.85 |
| 2025-05-06 | 16.52 |
| 2025-05-05 | 16.98 |
| 2025-05-02 | 16.93 |
| 2025-05-01 | 16.71 |
| 2025-04-30 | 16.89 |
| 2025-04-29 | 16.83 |
| 2025-04-28 | 16.75 |
| 2025-04-25 | 16.57 |